A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer

NCT00383266 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Esophageal Neoplasms

Interventions

DRUG: Pemetrexed
DRUG: Carboplatin

Sponsor

Washington University School of Medicine

Collaborators

[object Object]